Human alpha-fetoprotein (HAFP) isolated by immunoadsorbent column was shown to suppress the mitogenic response of human lymphocytes to phytomitogens, antihuman thymocyte antiserum, and the mixed lymphocyte culture. HAFP isolated from the sera and ascitic fluid of five hepatoma patients, and from fetal liver, varied in biological potency over three orders of magnitude. Extended agarose gel electrophoresis and crossed immunoelectrophoresis demonstrated three molecular species of HAFP. Quantitation of the three species revealed a correlation between the relative amount of the most negatively charged species and biological potency. Treatment of HAFP with neuraminidase to remove completely sialic acid residues did not alter the biological potency, but converted the three species to two species having slower electrophoretic mobilities. We conclude that differences in sialic acid content are only partly responsible for the microheterogeneity demonstrated by HAFP, and that variability in another charged moiety is also present. Variation in the relative proportions of the different molecular species of HAFP may be important in the regulation of its immunosuppressive properties. While characterizing the immunosuppressive effects of human alpha-fetoprotein (HAFP) (1), we noted that HAFP isolates from the serum and ascitic fluid of five patients with hepatoma or from fetal sources varied over three orders of magnitude in their capacity to inhibit in vitro human lymphocyte transformation induced by phytomitogens, antihuman thymocyte antiserum (ATS), and the mixed lymphocyte culture (MLC) (2). The most potent HAFP preparation was that isolated from fetal liver homogenates of stillborn human abortuses of 10-20 weeks' gestation (2). Because HAFP isolates display a microheterogeneity with respect to charge (3, 4), presumably due to differences in sialic acid content, we undertook a study of the effects of such charge differences upon the biological potency of our various preparations. The results indicate that the most negatively charged species of HAFP are those with the greatest capability to suppress the mitogenic responses of human lymphocytes in vitro. We also observed that total desialylation of HAFP preparations does not affect their biological potency, nor does it abolish their microheterogeneity.
. The most potent HAFP preparation was that isolated from fetal liver homogenates of stillborn human abortuses of [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] weeks' gestation (2) . Because HAFP isolates display a microheterogeneity with respect to charge (3, 4) , presumably due to differences in sialic acid content, we undertook a study of the effects of such charge differences upon the biological potency of our various preparations. The results indicate that the most negatively charged species of HAFP are those with the greatest capability to suppress the mitogenic responses of human lymphocytes in vitro. We also observed that total desialylation of HAFP preparations does not affect their biological potency, nor does it abolish their microheterogeneity.
MATERIALS AND METHODS
Human alpha-fetoprotein was isolated from sera and ascitic fluid of five hepatoma patients (Od., McF., Ho., Cr., and Lu.) by a modification of the method of Hirai et al. (1, 2, 5) . After elution from the immunoadsorbent column, and prior to passage over Sephadex G-150, the HAFP eluate was passed over a second immunoadsorbent column to which the Na2SO4-precipitated globulin fraction of rabbit antihuman serum antibody was attached. HAFP was also isolated from the livers of still-born human abortuses of 10-20 weeks' gestation. The livers were homogenized in phosphate-buffered saline at pH 7.4, centrifuged at 20,000 X g for 1 hr (40), and the soluble liver extract was subjected to the procedures described above.
The techniques for the isolation of peripheral blood lymphocytes from normal human adults, as well as methods for their culture, have been described previously (6, 7) . The potency of HAFP preparations in suppressing human lymphocyte transformation was derived from dose-response curves plotted on semilogarithmic graph paper and is expressed as the concentration of HAFP required to produce 50% inhibition. The following concentrations of mitogen were employed: Concanavalin A (Con A), 100 ,g/ml; phytohemagglutinin, 10 ,ug/ml; pokeweed mitogen, 0.08,ug/ml; ATS, 25,ul/ml.
Sialic acid quantitations were done by a modification of the method of Warren (8, 9) . After exhaustive dialysis against distilled water at 40, HAFP preparations were lyophilized and acid desialylation was performed in 0.03 M HCl at 800 for 45 min.
Enzymatic desialylation was carried out with a neuraminidase derived from Clostridium perfringens (Sigma Chemical Co., St. Louis, Mo.). HAFP (2 mg/ml) was digested with 0.06 units of enzyme per ml at 370 in phosphate-buffered saline at pH 7.0) for periods of up to 18 hr. Under these conditions, digestion was complete by 3 hr, as monitored by measurement of the release of free sialic acid. After neuraminidase digestion, portions of the desialylated HAFP were heated at 600 for 1 hr to inactivate residual neuraminidase, a procedure which was shown not to affect the electrophoretic mobility or biological activity of native HAFP (2 (Table 2 ). Because previous workers had noted microheterogeneity of HAFP by means of crossed immunoelectrophoresis (3, 4) , we applied this technique to a study of our purified HAFP preparations, and of the sera from which they were isolated. When concentrated solutions of purified hepatoma HAFP (10 mg/ml) were examined by one-dimensional agarose gel electrophoresis, three bands, the intensity of which varied from one isolate to another, were easily discerned (Fig. 1) (Fig. 2) . The relative proportions of the three peaks in a given isolate were constant when the sample was quantitated by crossed immunoelectrophoresis and by spectrophotometric scanning. In each of three instances in which fresh-frozen (-85°) serum was available for study, similar heterogeneity of HAFP could be discerned (Fig. 2F) . When the hepatoma HAFP isolates were completely desialylated by neuraminidase digestion, two HAFP peaks were seen consistently; the most anode-migrating one now had an electrophoretic mobility corresponding to the most cathode-migrating peak previously seen in the native HAFP isolate (Fig. 2F) . The most cathode-migrating of the desialylated HAFP peaks was termed HAFP 0.
Analysis of fetal liver HAFP (800 ,ug/ml) by similar techniques revealed the presence of a single peak whose mobility corresponded to the most anode-migrating one of the native hepatoma HAFP species. Desialylated fetal liver HAFP also revealed a single peak, which was now shifted to the position of the most cathodal native hepatoma HAFP band (Fig. 2F) . The similarity of the differences in RF between neighboring 
